Stock quote - News

AstraZeneca
AZN: 7,250.00 +2.00 ( +0.03 %) delayed: 05:00AM


  • UK stocks claw-back some losses, but still close down on the day
    Monday 11 Nov 2019 16:39

    UK stocks clawed back some of their earlier losses on Monday as a mix of political tensions in Hong Kong and weaker than expected growth in UK third-quarter Gross Domestic Product (GDP) weighed on investors. At 1630, the benchmark FTSE 100 index was down 35.29 points, or 0.5%, at 7,324.09. BHP...
    Read more

  • UK stocks accelerate to the downside at midday
    Monday 11 Nov 2019 12:07

    UK stocks saw accelerated losses on Monday after a weak start in reaction to a violent escalation of political tensions in Hong Kong sent Asian exchanges lower. Adding pressure to stocks was weaker than expected UK third-quarter Gross Domestic Product (GDP), which came in at 0.3% versus 0.4%...
    Read more

  • FTSE opens 0.5% down amid escalation in Hong Kong tensions
    Monday 11 Nov 2019 09:01

    UK stocks opened weaker on Monday after a violent escalation of political tensions in Hong Kong sent Asian exchanges lower. At 0852, the benchmark FTSE 100 index was down 38.41 points, or 0.5%, at 7.320.97. BHP fell 1.8% to £16.966 after the mining titan unveiled ambitious growth targets for...
    Read more

  • AstraZeneca's drug to treat anaemia in kidney disease patients meets primary goal
    Monday 11 Nov 2019 07:30

    AstraZeneca said pooled analyses had shown that its drug used to treat patients with anaemia from chronic kidney disease had met its primary goal with no increased cardiovascular risk. The pooled cardiovascular (CV) safety analyses showed that roxadustat did not increase the risk of major...
    Read more

  • AstraZeneca reports positive trial results for drug to treat anaemia in kidney disease patients
    Friday 08 Nov 2019 07:58

    AstraZeneca said results from clinical trials showed that a drug to treat patients with anaemia from chronic kidney disease had significantly increased red haemoglobin levels. The so-called Olympus trial compared AstraZeneca's roxadustat to placebo while the Rockies trial compared the drug to...
    Read more

  • Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC
    Wednesday 30 Oct 2019 08:00

    Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8300p (from 7800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
    Read more

  • AstraZeneca sells rights to schizophrenia and bipolar drugs in Europe and Russia to Cheplapharm
    Wednesday 30 Oct 2019 07:45

    AstraZeneca said it had agreed to sell and licence the commercial rights to its schizophrenia and bipolar drugs in Europe and Russia to Cheplapharm. Seroquel and Seroquel XR used primarily to treat schizophrenia and bipolar disorder, had lost their compound patent protection in Europe and...
    Read more

  • Broker Forecast - Kepler Cheuvreux issues a broker note on AstraZeneca PLC
    Tuesday 29 Oct 2019 10:50

    Kepler Cheuvreux today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8000p (from 7700p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
    Read more

  • Broker Forecast - UBS issues a broker note on AstraZeneca PLC
    Tuesday 29 Oct 2019 09:40

    UBS today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 5800p (from 5700p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
    Read more

  • Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC
    Friday 25 Oct 2019 08:40

    Liberum Capital today upgrades its investment rating on AstraZeneca PLC (LON:AZN) to buy (from hold). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
    Read more

  • UK market boosted by AstraZeneca, Aveva results
    Thursday 24 Oct 2019 16:36

    The FTSE 100 ended the day towards its highs despite continued government wrangling over the prime minister's withdrawal bill agreement and election rumours swirling around Westminster. The FTSE 100 index of leading gained 59 points or 0.8% to 7,319 heading into the close. AstraZeneca moved...
    Read more

  • FSTE gains ground on AstraZeneca sales while RBS slips
    Thursday 24 Oct 2019 12:00

    The FTSE 100 traded higher on Thursday as the government continued to wrangle over the prime minister's withdrawal bill agreement. The ongoing uncertainty failed to dent UK shares, and at midday the UK's benchmark index was up 0.9% to 7,328. AstraZeneca moved 3.9% higher to £71.87, after it...
    Read more

  • AstraZeneca upgrade lifts FTSE 100; RBS slumps on operating loss
    Thursday 24 Oct 2019 09:21

    The FTSE 100 has opened higher as the UK government continues to wrangle over the prime minister's withdrawal bill agreement. The ongoing uncertainty has failed to dent UK shares, and at 8.58am the UK's benchmark index was up 0.81%, up 58.51 points, to 7,319.25. AstraZeneca moved 2.7% higher to...
    Read more

  • AstraZeneca upgrades sales guidance following 16% growth in Q3
    Thursday 24 Oct 2019 07:45

    AstraZeneca upgraded its guidance on product sales following a 16% rise in the third quarter of the year, led by growth in its portfolio of cancer drugs. Product sales at constant currency were now expected to increase by a low to mid-teens percentage; the prior guidance was for a low...
    Read more

  • UK stocks open 0.6% higher after key Brexit vote delayed
    Monday 21 Oct 2019 08:55

    UK stocks opened higher on Monday after Asian exchanges were lifted by hopes of progress in US-China trade talks, and a further delay on parliament's vote on Boris Johnson's Brexit deal pressured the pound. At 0843, the benchmark FTSE 100 index was up 45.17 points, or 0.6%, at 7.195.74. Food...
    Read more

  • AstraZeneca drug approved in US to reduce risk of heart failure in type-2 diabetes patients
    Monday 21 Oct 2019 07:31

    AstraZeneca said its type-2 diabetes drug was approved by US regulators to reduce the risk of hospitalisation for heart failure in adults with the condition and established cardiovascular disease. The approval came on the back of results from a Declare-Timi 58 cardiovascular outcomes trial...
    Read more

  • UK stocks hold onto gains following Brexit breakthrough
    Thursday 17 Oct 2019 16:34

    Having surged in morning trading after prime minister Johnson and European Commission president Juncker said that the two sides had reached a 'fair agreement' on Brexit, UK stocks held onto most of their gains at the close. At 4.30pm the FSTE 100 index of leading stocks was up 38 points or 0.5%...
    Read more

  • UK stocks boosted by news of Brexit breakthrough
    Thursday 17 Oct 2019 13:22

    UK stocks surged in midday trading after UK prime minister Johnson and European Commission president Juncker said that the two sides had reached a 'fair agreement' on Brexit. The pound rallied further against the dollar to hit $1.29 as well as gaining ground against the euro. At 1pm the FSTE...
    Read more

  • FTSE flat as traders watch for Brexit clarity
    Thursday 17 Oct 2019 09:59

    UK stocks remained largely flat in early trading as clarity was in short supply around the UK's negotiations with Brussels around securing a potential Brexit deal. The pound had slipped against the euro from around €1.16 to €1.15 by the opening bell. Opening at 7,175, the FTSE 100 had only...
    Read more

  • AstraZeneca's breast cancer drug granted priority review in US
    Thursday 17 Oct 2019 08:20

    AstraZeneca said the US Food and Drug Administration had granted the priority review for its metastatic breast cancer drug. The review date for the drug was set for the cancer drug, was set for the second quarter of 2020. 'Trastuzumab deruxtecan has the potential to transform the treatment...
    Read more

  • Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC
    Tuesday 15 Oct 2019 09:20

    Jefferies International today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 6700p (from 6550p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
    Read more

  • UK stocks rally as fears over US economy ease
    Friday 04 Oct 2019 16:43

    UK stocks rallied from Thursday's eight-month low heading into the weekend despite US employment data which missed estimates, fuelling concerns about the health of the world's biggest economy. At 4.30pm the benchmark FTSE 100 index was up 61 points or 0.9% at 7,138. BP shares gained 1.8% to...
    Read more

  • FTSE holds gains ahead of US jobs data
    Friday 04 Oct 2019 12:02

    UK stocks rebounded from Thursday's eight-month low heading into the weekend although investors remained braced for the release of monthly US employment data later in the day, amid growing concerns about the health of the world's biggest economy. At midday the benchmark FTSE 100 index was up 15...
    Read more

  • UK stocks open 0.3% higher; investors eye US jobs data
    Friday 04 Oct 2019 09:05

    UK stocks opened 0.3% higher on Friday as investors braced for the release of monthly US employment data later in the day, amid growing concerns about the health of the world's biggest economy. At 0839, the benchmark FTSE 100 index was up 23.41 points, or 0.3%, at 7,101.05 points. BP gained...
    Read more

  • AstraZeneca's respiratory drug gets regulatory nod in US for self-administration
    Friday 04 Oct 2019 07:26

    AstraZeneca said the US Food and Drug Administration had approved the self-administration of the company’s respiratory medication in a pre-filled pen. The company said it ‘can now offer Fasenra in an even more convenient way, giving US healthcare providers and patients the option of...
    Read more

  • Investors spooked by US manufacturing shock
    Tuesday 01 Oct 2019 16:37

    The FTSE 100 was firmly in reverse by the close after the worst reading of the US manufacturing sector since 2009. The index was down 0.65% at 7,360.32, while in the US the S&P 500 was down 0.6% to 2,959.54 by 4.30pm UK time. LARGE AND MID CAP RISERS AND FALLERS Greggs fell 12.6% to...
    Read more

  • UK stocks track sideways as Ferguson rallies; Greggs falls
    Tuesday 01 Oct 2019 09:02

    UK stocks were flat in early trading on Tuesday amid the release of mixed corporate results, including a higher profit from plumbing group Ferguson but disappointing sales update from bakery chain Greggs. At 0853, the benchmark FTSE 100 index was up 0.1 points at 7.408.31. Greggs fell 5.2% to...
    Read more

  • AstraZeneca sells rights to heartburn medication to Cheplapharm for up to $276m
    Tuesday 01 Oct 2019 08:00

    AstraZeneca said it had agreed to sell the global commercial rights for its heartburn medication and associated brands to Cheplapharm for up to $276m. Under the agreement, Cheplapharm would pay AstraZeneca approximately $243m on completion of the agreement, plus sales-contingent milestones of...
    Read more

  • AstraZeneca gets hit with complete response letter from FDA for lung disease treatment
    Tuesday 01 Oct 2019 07:54

    AstraZeneca said the US Food and Drug Administration (FDA) had rejected the company’s application for its lung disease treatment. The US Food and Drug Administration (FDA) had issued a complete response letter regarding the New Drug Application (NDA) for the company’s PT010 treatment, an...
    Read more

  • UK stocks end the day flat
    Monday 30 Sep 2019 16:33

    UK stocks traded in a narrow range on Monday as investors grappled with ongoing Brexit uncertainty and lingering trade tension between the US and China. UK data on mortgage lending showed that mortgage approvals had fallen more than expected in August. At 1630, the benchmark FTSE 100 index was...
    Read more

  • UK stocks turn slightly lower at midday
    Monday 30 Sep 2019 12:03

    UK stocks were slightly lower on Monday as investors grappled with ongoing Brexit uncertainty and lingering trade tension between the US and China. UK data on mortgage lending showed that mortgage approvals had fallen more than expected in August. At 1200, the benchmark FTSE 100 index had...
    Read more

  • UK stocks edge higher as Brexit, trade tensions simmer
    Monday 30 Sep 2019 09:11

    UK stocks edged only slightly higher on Monday as investors grappled with ongoing Brexit uncertainty and lingering trade tension between the US and China. At 0858, the benchmark FTSE 100 index had risen 2.99 points to 7.429.20. Pharmaceutical giant GlaxoSmithKline added 1.7% to 1,754.4p after...
    Read more

  • AstraZeneca, Merck post positive study results for ovarian cancer treatment
    Monday 30 Sep 2019 08:03

    Pharmaceutical companies AstraZeneca and Merck said they had recorded positive results from a trial of a treatment of ovarian cancer. The companies released positive results from a Phase III PAOLA-1 trial of Lynparza, also known as olaparib. The treatment demonstrated a statistically...
    Read more

  • Airlines take off following Thomas Cook collapse
    Monday 23 Sep 2019 16:42

    With markets spending Monday in the red on weak Eurozone PMI surveys, the FTSE 100 index spent the bulk of the session at a loss. However, the decline was moderated by losses for the pound due to Brexit anxiety and outperformance from airlines as investors looked to possible winners in the wake...
    Read more

  • FTSE falls as trade tensions linger and Thomas Cook collapses
    Monday 23 Sep 2019 11:49

    UK stocks traded lower on Monday following the release of weak French and German manufacturing data, while concerns lingered over the state of US-China trade relations. At 11.30, the benchmark FTSE 100 index was down 47.3 points, or 0.64%, at 7,297.59. LARGE AND MID CAP RISERS AND FALLERS...
    Read more

  • AstraZeneca sees Qtrilemt recommended for approval in EU
    Monday 23 Sep 2019 07:19

    AstraZeneca has announced that Qtrilment has been recommended for marketing authorisation in the EU by the Committe for Medicinal Products for Human Use (CHMP). The CHMP recommended this for Qtrilmet to improve glycaemic control when metformin with or without SU eor ither saxagliptin or...
    Read more

  • FTSE treads water with Fed decision in focus
    Wednesday 18 Sep 2019 11:58

    Ahead of a decision later from the US Federal Reserve on interest rates, the FTSE 100 was marking time, up a handful of points at 7,324.76. Defence firm Cobham dipped 0.5% to 159.75p as the Government announced a probe into national security concerns over its £4bn takeover by US private equity...
    Read more

  • UK stocks open slightly lower as investors await Fed rates decision
    Wednesday 18 Sep 2019 08:53

    UK stocks opened slightly lower on Wednesday as investors braced for an upcoming decision on interest rates from the US Federal Reserve later in the day. Most market watchers expect a 25 basis point rate cut. At 0846, the benchmark FTSE 100 index was down 4.19 points at 7.316.21. DIY group...
    Read more

  • AstraZeneca amends collaboration with Ironwood
    Wednesday 18 Sep 2019 07:16

    AstraZeneca has amended its collaboration agreement with Ironwood Pharmaceuticals in China mainland, China Hong Kong, and China Macau for Linzess. This new agreement gives AstraZeneca full responsibility for developing, manufacturing, and commercialising Linzess in China. Linzess is a...
    Read more

  • Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC
    Friday 13 Sep 2019 10:10

    Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8200p (from 8000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
    Read more

  • Broker Forecast - Citigroup issues a broker note on AstraZeneca PLC
    Wednesday 11 Sep 2019 08:10

    Citigroup today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 10000p (from 7000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
    Read more

  • Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC
    Monday 09 Sep 2019 09:50

    Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7800p (from 7600p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
    Read more

  • AstraZeneca says lung cancer treatment reduced death rates by 27%
    Monday 09 Sep 2019 08:56

    AstraZeneca said results from a clinical trial showed its lung cancer drug reduced the risk of death by more than a fifth in patients with previously-untreated extensive-stage small cell lung cancer. Imfinzi in combination with four cycles of standard-of-care (SoC) chemotherapy - etoposide...
    Read more

  • Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC
    Friday 06 Sep 2019 12:40

    Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8000p (from 7800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
    Read more

  • AstraZeneca lung cancer treatment gets regulatory nod in China
    Wednesday 04 Sep 2019 07:41

    AstraZeneca said its lung cancer drug received marketing approval in China as a 1st-line treatment based on results from a clinical trial. In the Flaura trial, 1st-line use of lung cancer drug Tagrisso provided a statistically-significant and clinically- meaningful improvement in...
    Read more

  • UK stocks hold on to gains at close
    Monday 02 Sep 2019 16:22

    UK stocks held on to earlier gains on Monday in what is set to be a pivotal week for British politics, as Boris Johnson faces potential attacks on his aggressive Brexit strategy and possibly his leadership from Tory rebels. At 1610, the benchmark FTSE 100 index was up 94.22 points, or 1.3%, at...
    Read more

  • UK stocks add to gains at midday
    Monday 02 Sep 2019 11:50

    UK stocks added to earlier gains on Monday in what is set to be a pivotal week for British politics, as Boris Johnson faces potential attacks on his aggressive Brexit strategy and possibly his leadership from Tory rebels. At 1140, the benchmark FTSE 100 index was up 95.63 points, or 1.3%, at...
    Read more

  • UK stocks open 0.6% higher as Brexit drama intensifies
    Monday 02 Sep 2019 09:03

    UK stocks opened higher on Monday in what is set to be a pivotal week for British politics, as Boris Johnson faces potential attacks on his aggressive Brexit strategy and possibly his leadership from Tory rebels. At 0854, the benchmark FTSE 100 index was up 41.66 points, or 0.6%, at 7.248.84....
    Read more

  • Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC
    Monday 02 Sep 2019 08:40

    Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7600p (from 7200p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
    Read more

  • AstraZeneca diabetes drug combined with standard care shows reduction in heart failure
    Monday 02 Sep 2019 07:28

    AstraZeneca said its type-2 diabetes drug on top of standard care showed a reduction in both the incidence of cardiovascular death and the worsening of heart failure in patients with and without type-2 diabetes. The trial of Farxiga (dapagliflozin) on top of standard of care showed a 30%...
    Read more

Page 1 |

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.